Journal
CLINICAL CANCER RESEARCH
Volume 28, Issue 24, Pages 5233-5234Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-22-2707
Keywords
-
Categories
Funding
- Norwegian Cancer Society
- South-Eastern Norway Regional Health Authority
- [182451]
Ask authors/readers for more resources
A phase II trial investigated the potential of using metformin to reduce hypoxia in cervical cancer. The study used imaging to select patients and test the biological hypothesis behind the drug effect, which is of importance for targeted treatment in the clinic.
A phase II trial, investigating whether the antidiabetic drug metformin could reduce hypoxia in cervical cancer, used imaging to preselect patients and test the biological hypothesis behind the drug effect. This trial design would be of importance for the implementation of targeted treatment in the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available